Filing Details

Accession Number:
0001179110-12-015874
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-09 16:15:22
Reporting Period:
2012-11-07
Filing Date:
2012-11-09
Accepted Time:
2012-11-09 16:15:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
21510 Coherent Inc COHR Laboratory Analytical Instruments (3826) 941622541
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1207626 Lawrence Tomlinson P.o. Box 54980
Santa Clara CA 95056-0980
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-07 6,000 $27.93 9,800 No 4 M Direct
Common Stock Acquisiton 2012-11-07 6,000 $15.21 15,800 No 4 M Direct
Common Stock Acquisiton 2012-11-07 6,000 $32.00 21,800 No 4 M Direct
Common Stock Disposition 2012-11-07 21,800 $43.60 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non Qualified Stock Option (right to buy) Disposition 2012-11-07 6,000 $0.00 6,000 $27.93
Common Stock Non Qualified Stock Option (right to buy) Disposition 2012-11-07 6,000 $0.00 6,000 $15.21
Common Stock Non Qualified Stock Option (right to buy) Disposition 2012-11-07 6,000 $0.00 6,000 $32.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,500 2018-03-19 No 4 M Direct
11,500 2019-03-11 No 4 M Direct
5,500 2020-04-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,200 Indirect Family Trust
Footnotes
  1. Sold Pursuant to a Rule 10b5-1 sales plan adopted on May 27, 2012.
  2. Represents the weighted average sales price for the shares. The range of prices for such sales was $43.00 to $44.06. The reporting person will provide upon request full information regarding the number of shares sold at each separate price.
  3. The shares subject to the option are fully vested and exercisable.